BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou T, Yuan Z, Weng J, Pei D, Du X, He C, Lai P. Challenges and advances in clinical applications of mesenchymal stromal cells. J Hematol Oncol. 2021;14:24. [PMID: 33579329 DOI: 10.1186/s13045-021-01037-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Wan Kamarul Zaman WS, Nurul AA, Nordin F. Stem Cells and Cancer Stem Cells: The Jekyll and Hyde Scenario and Their Implications in Stem Cell Therapy. Biomedicines 2021;9:1245. [PMID: 34572431 DOI: 10.3390/biomedicines9091245] [Reference Citation Analysis]
2 Li Z, Zhang M, Zheng J, Tian Y, Zhang H, Tan Y, Li Q, Zhang J, Huang X. Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Improve Ovarian Function and Proliferation of Premature Ovarian Insufficiency by Regulating the Hippo Signaling Pathway. Front Endocrinol (Lausanne) 2021;12:711902. [PMID: 34456868 DOI: 10.3389/fendo.2021.711902] [Reference Citation Analysis]
3 Cho H, Lee S, Park J, Kwak YH, Kweon H, Kang D. Competitive Hybridization of a Microarray Identifies CMKLR1 as an Up-Regulated Gene in Human Bone Marrow-Derived Mesenchymal Stem Cells Compared to Human Embryonic Fibroblasts. CIMB 2022;44:1497-512. [DOI: 10.3390/cimb44040102] [Reference Citation Analysis]
4 Mohana Devi S, Abishek Kumar B, Mahalaxmi I, Balachandar V. Leber's hereditary optic neuropathy: Current approaches and future perspectives on Mesenchymal stem cell-mediated rescue. Mitochondrion 2021;60:201-18. [PMID: 34454075 DOI: 10.1016/j.mito.2021.08.013] [Reference Citation Analysis]
5 Li Z, Zhang M, Tian Y, Li Q, Huang X. Mesenchymal Stem Cells in Premature Ovarian Insufficiency: Mechanisms and Prospects. Front Cell Dev Biol 2021;9:718192. [PMID: 34414193 DOI: 10.3389/fcell.2021.718192] [Reference Citation Analysis]
6 Meldolesi J. News about Therapies of Alzheimer’s Disease: Extracellular Vesicles from Stem Cells Exhibit Advantages Compared to Other Treatments. Biomedicines 2022;10:105. [DOI: 10.3390/biomedicines10010105] [Reference Citation Analysis]
7 Brooks B, Ebedes D, Usmani A, Gonzales-portillo JV, Gonzales-portillo D, Borlongan CV. Mesenchymal Stromal Cells in Ischemic Brain Injury. Cells 2022;11:1013. [DOI: 10.3390/cells11061013] [Reference Citation Analysis]
8 Fageeh HN. Preliminary Evaluation of Proliferation, Wound Healing Properties, Osteogenic and Chondrogenic Potential of Dental Pulp Stem Cells Obtained from Healthy and Periodontitis Affected Teeth. Cells 2021;10:2118. [PMID: 34440887 DOI: 10.3390/cells10082118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lara-Barba E, Araya MJ, Hill CN, Bustamante-Barrientos FA, Ortloff A, García C, Galvez-Jiron F, Pradenas C, Luque-Campos N, Maita G, Elizondo-Vega R, Djouad F, Vega-Letter AM, Luz-Crawford P. Role of microRNA Shuttled in Small Extracellular Vesicles Derived From Mesenchymal Stem/Stromal Cells for Osteoarticular Disease Treatment. Front Immunol 2021;12:768771. [PMID: 34790203 DOI: 10.3389/fimmu.2021.768771] [Reference Citation Analysis]
10 Owen-Woods C, Kusumbe A. Fundamentals of bone vasculature: Specialization, interactions and functions. Semin Cell Dev Biol 2021:S1084-9521(21)00185-3. [PMID: 34281770 DOI: 10.1016/j.semcdb.2021.06.025] [Reference Citation Analysis]
11 Pang Q, Yang R, Zhang M, Zou W, Qian N, Xu Q, Chen H, Peng J, Luo X, Zhang Q, Zhang T, Chapel A. Peripheral Blood-Derived Mesenchymal Stem Cells Modulate Macrophage Plasticity through the IL-10/STAT3 Pathway. Stem Cells International 2022;2022:1-19. [DOI: 10.1155/2022/5181241] [Reference Citation Analysis]
12 Racchetti G, Meldolesi J. Extracellular Vesicles of Mesenchymal Stem Cells: Therapeutic Properties Discovered with Extraordinary Success. Biomedicines 2021;9:667. [PMID: 34200818 DOI: 10.3390/biomedicines9060667] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Weng Z, Zhang B, Wu C, Yu F, Han B, Li B, Li L. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer. J Hematol Oncol 2021;14:136. [PMID: 34479611 DOI: 10.1186/s13045-021-01141-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Do AD, Kurniawati I, Hsieh CL, Wong TT, Lin YL, Sung SY. Application of Mesenchymal Stem Cells in Targeted Delivery to the Brain: Potential and Challenges of the Extracellular Vesicle-Based Approach for Brain Tumor Treatment. Int J Mol Sci 2021;22:11187. [PMID: 34681842 DOI: 10.3390/ijms222011187] [Reference Citation Analysis]
15 Yuan L, You H, Qin N, Zuo W. Interleukin-10 Modulates the Metabolism and Osteogenesis of Human Dental Pulp Stem Cells. Cell Reprogram 2021;23:270-6. [PMID: 34491831 DOI: 10.1089/cell.2021.0044] [Reference Citation Analysis]
16 Wruck W, Graffmann N, Spitzhorn LS, Adjaye J. Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Acquire Rejuvenation and Reduced Heterogeneity. Front Cell Dev Biol 2021;9:717772. [PMID: 34604216 DOI: 10.3389/fcell.2021.717772] [Reference Citation Analysis]
17 Najar M, Merimi M, Faour WH, Lombard CA, Moussa Agha D, Ouhaddi Y, Sokal EM, Lagneaux L, Fahmi H. In Vitro Cellular and Molecular Interplay between Human Foreskin-Derived Mesenchymal Stromal/Stem Cells and the Th17 Cell Pathway. Pharmaceutics 2021;13:1736. [PMID: 34684029 DOI: 10.3390/pharmaceutics13101736] [Reference Citation Analysis]
18 Liu Y, Zhou X, Liu X, Jiang X. The immunology and immunotherapy for COVID-19. Expert Rev Mol Med 2021;23:e24. [PMID: 34915958 DOI: 10.1017/erm.2021.30] [Reference Citation Analysis]
19 Hu S, Xing H, Zhang J, Zhu Z, Yin Y, Zhang N, Qi Y, Li YS. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Immunomodulatory Effects and Potential Applications in Intervertebral Disc Degeneration. Stem Cells International 2022;2022:1-13. [DOI: 10.1155/2022/7538025] [Reference Citation Analysis]
20 Kwak J, Choi W, Bae Y, Kim M, Choi S, Oh W, Jin H. HLA-A2 Promotes the Therapeutic Effect of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Hyperoxic Lung Injury. Bioengineering 2022;9:177. [DOI: 10.3390/bioengineering9040177] [Reference Citation Analysis]
21 Wang J, Huang D, Yu H, Cheng Y, Ren H, Zhao Y. Developing tissue engineering strategies for liver regeneration. Engineered Regeneration 2022. [DOI: 10.1016/j.engreg.2022.02.003] [Reference Citation Analysis]
22 Alvites R, Branquinho M, Sousa AC, Lopes B, Sousa P, Maurício AC. Mesenchymal Stem/Stromal Cells and Their Paracrine Activity—Immunomodulation Mechanisms and How to Influence the Therapeutic Potential. Pharmaceutics 2022;14:381. [DOI: 10.3390/pharmaceutics14020381] [Reference Citation Analysis]
23 Coburn PT, Li X, Li J, Kishimoto Y, Li-jessen NYK. Progress in Vocal Fold Regenerative Biomaterials: An Immunological Perspective. Advanced NanoBiomed Research 2022;2:2100119. [DOI: 10.1002/anbr.202100119] [Reference Citation Analysis]
24 Pawar M, Pawar V, Renugalakshmi A, Albrakati A, Uthman US, Dewan H, Mugri M, Sayed M, Bhandi S, Patil VR, Reda R, Testarelli L, Patil S. Glucose and Serum Deprivation Led to Altered Proliferation, Differentiation Potential and AMPK Activation in Stem Cells from Human Deciduous Tooth. J Pers Med 2021;12:18. [PMID: 35055333 DOI: 10.3390/jpm12010018] [Reference Citation Analysis]
25 Zhang X, Jin X, Sun R, Zhang M, Lu W, Zhao M. Gene knockout in cellular immunotherapy: Application and limitations. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215736] [Reference Citation Analysis]
26 Vig S, Fernandes MH. Bone Cell Exosomes and Emerging Strategies in Bone Engineering. Biomedicines 2022;10:767. [DOI: 10.3390/biomedicines10040767] [Reference Citation Analysis]
27 Sadanandan N, Shear A, Brooks B, Saft M, Cabantan DAG, Kingsbury C, Zhang H, Anthony S, Wang ZJ, Salazar FE, Lezama Toledo AR, Rivera Monroy G, Vega Gonzales-Portillo J, Moscatello A, Lee JY, Borlongan CV. Treating Metastatic Brain Cancers With Stem Cells. Front Mol Neurosci 2021;14:749716. [PMID: 34899179 DOI: 10.3389/fnmol.2021.749716] [Reference Citation Analysis]
28 Shen M, Chen T. Mesenchymal Stem Cell-Derived Exosomes and Their Potential Agents in Hematological Diseases. Oxid Med Cell Longev 2021;2021:4539453. [PMID: 34621464 DOI: 10.1155/2021/4539453] [Reference Citation Analysis]
29 Razazian M, Khosravi M, Bahiraii S, Uzan G, Shamdani S, Naserian S. Differences and similarities between mesenchymal stem cell and endothelial progenitor cell immunoregulatory properties against T cells. World J Stem Cells 2021; 13(8): 971-984 [PMID: 34567420 DOI: 10.4252/wjsc.v13.i8.971] [Reference Citation Analysis]